aod9604 protocol AOD-9604 activates GH receptors for lipolysis without triggering IGF-1 from the liver. That distinction matters for patients who need GH receptor signaling but must avoid IGF-1 elevation. It targets visceral adipose, insulin Always looking for ways to

This metabolic shift occurs due to the peptides action on the nicotinamide methylation pathway , which increases intracellular NAD+ availability, facilitating greater oxidative metabolism

The body continues to benefit from residual improvements during the off-cycle

Dosing and Administration Standard Dose : 50 mg once daily or as directed by a licensed healthcare provider Route : Oral capsule Timing : Preferably taken in the morning with or without food Duration : Often used in 48 week cycles depending on clinical goals Because 5-Amino-1MQ modulates key metabolic pathways, it is strongly recommended that patients be monitored by a practitioner, especially when used alongside other metabolic or NAD therapies

Lipotropic Injections

( Harvard T.H